Outstanding performance funds increased their exposure to the technology and pharmaceutical sectors in the second quarter.

As the second quarter report of the fund in 2025 gradually disclosed, the latest rebalancing situation of multiple outstanding performance funds has emerged. According to the quarterly report, in the volatile market in the second quarter, outstanding performance funds generally operated with high positions, and focused on increasing positions in the technology and pharmaceutical sectors. Looking ahead, fund managers generally have a positive view on the value of equity asset allocation, believing that there are many structural opportunities to grasp.